Kenji Harada
Keine laufenden Positionen mehr
Profil
Kenji Harada is currently a Director at Complexa, Inc. He was previously an Independent Director at TRACON Pharmaceuticals, Inc. from 2011 to 2015 and a Director at Sesen Bio, Inc. from 2012 to 2013.
He also held positions as a Principal at JAFCO Group Co., Ltd.
and a Manager at Toray International America, Inc. Dr. Harada received his undergraduate, graduate, and doctorate degrees from the University of Tokyo.
Ehemalige bekannte Positionen von Kenji Harada
| Unternehmen | Position | Ende |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 31.03.2015 |
| CARISMA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2013 |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | - |
| JAFCO GROUP CO., LTD. | Corporate Officer/Principal | - |
Toray International America, Inc.
 Toray International America, Inc. Wholesale DistributorsDistribution Services Part of Toray Industries, Inc., Toray International America, Inc. engages in trading of textiles, plastics and chemical products. The company is based in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Kenji Harada
| University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| JAFCO GROUP CO., LTD. | Finance |
| Private Unternehmen | 3 |
|---|---|
Toray International America, Inc.
Toray International America, Inc. Wholesale DistributorsDistribution Services Part of Toray Industries, Inc., Toray International America, Inc. engages in trading of textiles, plastics and chemical products. The company is based in New York, NY. | Distribution Services |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
